Journals / Medicine Science / 2021 / Cilt: 10 - Sayı: 3

Prevalence and predictors of 25-OH Vitamin D deficiency in peritoneal dialysis patients: A single center study

Pages
694–697
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Serum uric acid is an independent predictor of 25-OH vitamin D deficiency which should further be investigated in larger studies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Vitamin D has a critical role in bone-mineral disorders in chronic kidney disease (CKD) and its deficiency is further associated with increased cardiovascular morbidity and mortality among CKD patients.
📊
Key Findings & Data:We aimed to evaluate prevalence of vitamin D deficiency and investigate the laboratory and clinical parameters associated with 25-OH vitamin D deficiency in peritoneal dialysis (PD) patients.
💡
Conclusion & Impact:Serum uric acid is an independent predictor of 25-OH vitamin D deficiency which should further be investigated in larger studies.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Vitamin D has a critical role in bone-mineral disorders in chronic kidney disease (CKD) and its deficiency is further associated with increased cardiovascular morbidity and mortality among CKD patients. We aimed to evaluate prevalence of vitamin D deficiency and investigate the laboratory and clinical parameters associated with 25-OH vitamin D deficiency in peritoneal dialysis (PD) patients. Sixty-four (33M/31F) peritoneal dialysis patients were enrolled in this retrospective single center study. Clinical and laboratory data were obtained from patient charts. Prevalence of 25-OH vitamin D deficiency and its associations were analyzed. The patients’ mean age was 49.7±13.3 years and the mean duration of PD was 61.0±55.0 months. The mean 25-OH vitamin D level was 8.9±2.4 ng/ml and none of the patients were on 25-OH vitamin D therapy. All of the patients had lower than normal 25-OH vitamin D levels according to KDOQI guidelines. Levels of 25-OH vitamin D were deficient and insufficient in 84.4% (57.8% mild; 26.6% severe) and 15.6% of the patients, respectively. There was no association between 25-OH vitamin D levels and sex, age, BMI, duration of PD and cause of ESRD. There was a negative correlation between 25-OH vitamin D levels and uric acid and parathyroid hormone. Uric acid was an independent predictor of 25-OH vitamin D deficiency in the logistic regression analysis [OR (95%CI): 0.139 (0.029-0.667), p: 0.014]. We conclude that 25-OH vitamin D deficiency is very common in PD patients. Serum uric acid is an independent predictor of 25-OH vitamin D deficiency which should further be investigated in larger studies.

🔖

Cite This Article

ATAŞ, D. B., VELİOĞLU, A., TUĞCU, M., ARIKAN, H., AŞÇIOĞLU, E. (2021). Prevalence and predictors of 25-OH Vitamin D deficiency in peritoneal dialysis patients: A single center study. Medicine Science, Cilt: 10 - Sayı: 3, 694–697. https://ajindex.com/articles/401126

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Amer M, Qayyum R. Relationship between 25-hydroxyvitamin D and all-cause and cardiovascular disease mortality. Am J Med. 2013;126:509-14.
  2. Souberbielle JC, Body JJ, Lappe JM, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev. 2010;9:709-15.
  3. London GM, Guérin AP, Verbeke FH, et al. Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc of Nephrol. 2007;18:613-20.
  4. Gracia-Iguacel C, Gallar P, Qureshi AR, et al. Vitamin D deficiency in dialysis patients: effect of dialysis modality and implications on outcome. J Ren Nutr. 2010;20:359-67.
  5. Taskapan H, Ersoy FF, Passadakis PS, et al. Severe vitamin D deficiency in chronic renal failure patients on peritoneal dialysis. Clin Nephrol. 2006;66:247–55. González EA, Sachdeva A, Oliver DA, et al. Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol. 2004;24:503-10. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266-81.
  6. Brancaccio D, Cozzolino M. Cardiovascular effects of VDR and CaSR activation. G Ital Nefrol. 2009;26:18-22.
  7. Rojas-Rivera J, De La Piedra C, Ramos A, et al. The expanding spectrum of biological actions of vitamin D. Nephrol Dial Transplant. 2010; 25:2850-65.
  8. Melamed ML, Michos ED, Post W, et al. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168:1629-37.
  9. Ulutas O, Taskapan H, Taskapan MC, et al. Vitamin D deficiency, insulin resistance, serum adipokine, and leptin levels in peritoneal dialysis patients. Int Urol Nephrol. 2013;45:879-84. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009;(113):1-130.
  10. Nair R, Maseeh A. Vitamin D: The "sunshine" vitamin. J Pharmacol Pharmacother. 2012;3:118-26.
  11. Alpdemir M, Alpdemir MF. Vitamin D deficiency status in Turkey: A meta-analysis. Int J Med Biochem. 2019;2:118-31.
  12. Cho HY, Hyun HS, Kang HG, et al. Prevalence of 25(OH) Vitamin D insufficiency and deficiency in pediatric patients on chronic dialysis. Perit Dial Int. 2013;33:398-404.
  13. Shah N, Bernardini J, Piraino B. Prevalence and correction of 25(OH) Vitamin D deficiency in peritoneal dialysis patients. Perit Dial Int. 2005;25:362-6. M